Cargando…
[(64)Cu]XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinoma
Carbonic anhydrase IX (CAIX) is a cell surface enzyme that is over-expressed in approximately 95% of cases of clear cell renal cell carcinoma (ccRCC), the most common renal cancer. We synthesized and performed in vitro and in vivo evaluation of a dual-motif ligand, [(64)Cu]XYIMSR-06, for imaging CAI...
Autores principales: | Minn, Il, Koo, Soo Min, Lee, Hye Soo, Brummet, Mary, Rowe, Steven P., Gorin, Michael A., Sysa-Shah, Polina, Lewis, William D., Ahn, Hye-Hyun, Wang, Yuchuan, Banerjee, Sangeeta Ray, Mease, Ronnie C., Nimmagadda, Sridhar, Allaf, Mohamad E., Pomper, Martin G., Yang, Xing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302928/ https://www.ncbi.nlm.nih.gov/pubmed/27437764 http://dx.doi.org/10.18632/oncotarget.10602 |
Ejemplares similares
-
Imaging of carbonic anhydrase IX with an (111)In-labeled dual-motif inhibitor
por: Yang, Xing, et al.
Publicado: (2015) -
(64)Cu-Labeled Inhibitors
of Prostate-Specific
Membrane Antigen for PET Imaging of Prostate Cancer
por: Banerjee, Sangeeta Ray, et al.
Publicado: (2014) -
A Series of PSMA-Targeted Near-Infrared Fluorescent Imaging Agents
por: Chen, Ying, et al.
Publicado: (2022) -
Imaging CAR T cell therapy with PSMA-targeted positron emission tomography
por: Minn, Il, et al.
Publicado: (2019) -
Auger radiopharmaceutical therapy targeting prostate-specific membrane antigen in a micrometastatic model of prostate cancer
por: Shen, Colette J., et al.
Publicado: (2020)